Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Jan;28(1):15-23.
doi: 10.1038/s41418-020-00679-7. Epub 2020 Dec 1.

Trends and challenges in modeling glioma using 3D human brain organoids

Affiliations
Review

Trends and challenges in modeling glioma using 3D human brain organoids

Aruljothi Mariappan et al. Cell Death Differ. 2021 Jan.

Abstract

The human brain organoids derived from pluripotent cells are a new class of three-dimensional tissue systems that recapitulates several neural epithelial aspects. Brain organoids have already helped efficient modeling of crucial elements of brain development and disorders. Brain organoids' suitability in modeling glioma has started to emerge, offering another usefulness of brain organoids in disease modeling. Although the current state-of-the organoids mostly reflect the immature state of the brain, with their vast cell diversity, human brain-like cytoarchitecture, feasibility in culturing, handling, imaging, and tractability can offer enormous potential in reflecting the glioma invasion, integration, and interaction with different neuronal cell types. Here, we summarize the current trend of employing brain organoids in glioma modeling and discuss the immediate challenges. Solving them might lay a foundation for using brain organoids as a pre-clinical 3D substrate to dissect the glioma invasion mechanisms in detail.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1. Examples of iPSCs-derived human brain organoids.
A Brain organoids shown here exhibits morphologically similar appearances of human neural epithelial tissues with fluid-filled regions. The images adopted from Gabriel et al. EMBO Journal 2016. B Schematic illustrations of various glioma invasion assays that used patient derived GSCs and human brain organoids. Schemes also explain different methods of optimization and what they can reveal.

References

    1. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl J Med. 2005;352:987–96. doi: 10.1056/NEJMoa043330. - DOI - PubMed
    1. Burnet NG, Lynch AG, Jefferies SJ, Price SJ, Jones PH, Antoun NM, et al. High grade glioma: imaging combined with pathological grade defines management and predicts prognosis. Radiother Oncol. 2007;85:371–8. doi: 10.1016/j.radonc.2007.10.008. - DOI - PubMed
    1. Furnari FB, Fenton T, Bachoo RM, Mukasa A, Stommel JM, Stegh A, et al. Malignant astrocytic glioma: genetics, biology, and paths to treatment. Genes Dev. 2007;21:2683–710. doi: 10.1101/gad.1596707. - DOI - PubMed
    1. Buckner JC. Factors influencing survival in high-grade gliomas. Semin Oncol. 2003;30:10–4. doi: 10.1053/j.seminoncol.2003.11.031. - DOI - PubMed
    1. Rusthoven CG, Koshy M, Sher DJ. Radiation plus temozolomide in patients with glioblastoma. N. Engl J Med. 2017;376:2195–7. doi: 10.1056/NEJMc1704726. - DOI - PubMed

Publication types